title: Mutations of the SL2 dimerization sequence of the hepatitis C genome abrogate viral replication.
abstract: Stem-loop SL2 is a self-interacting palindromic sequence that has been identified within the hepatitis C virus genome (HCV). While, RNA dimerization of the HCV genome has been observed in vitro with short RNA sequences, the role of a putative RNA dimerization during viral replication has not been elucidated. To determine the effect of genomic dimerization on viral replication, we introduced mutations into SL2 predicted to disrupt genomic dimerization. Using surface plasmon resonance, we show that mutations within the SL2 bulge impact dimerization in vitro. Transfection of Huh7 cells with luciferase-encoding full-length genomes containing SL2 mutations abolishes viral replication. Luciferase expression indicates that viral translation is not or slightly affected and that the viral RNA is properly encapsidated. However, RT-qPCR analysis demonstrates that viral RNA synthesis is drastically decreased. In vitro synthesis experiments using the viral recombinant polymerase show that modifications of intra-molecular interactions have no effect on RNA synthesis, while impairing inter-molecular interactions decreases polymerase activity. This confirms that dimeric templates are preferentially replicated by the viral polymerase. Altogether, these results indicate that the dimerization of the HCV genomic RNA is a crucial step for the viral life cycle especially for RNA replication. RNA dimerization could explain the existence of HCV recombinants in cell culture and patients reported recently in other studies.
authors.affiliation: Univ. Bordeaux, Laboratoire MFP, 33076, Bordeaux, France.
authors.forename: Cyril
authors.initials: C
authors.lastname: Masante
authors.forename: Chloé
authors.initials: C
authors.lastname: Jaubert
authors.forename: William
authors.initials: W
authors.lastname: Palau
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Plissonneau
authors.forename: Lucie
authors.initials: L
authors.lastname: Besnard
authors.forename: Michel
authors.initials: M
authors.lastname: Ventura
authors.forename: Carmelo
authors.initials: C
authors.lastname: Di Primo
mesh_terms: D020029:Base Pairing; D002460:Cell Line; D017931:DNA Primers / Q000235:genetics; D019281:Dimerization; D005822:Genetic Vectors / Q000235:genetics; D016679:Genome, Viral / Q000235:genetics*; D016174:Hepacivirus / Q000235:genetics*; D006801:Humans; D055029:Inverted Repeat Sequences / Q000235:genetics*; D008156:Luciferases; D009154:Mutation / Q000235:genetics*; D009841:Oligonucleotides / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D020349:Surface Plasmon Resonance; D014779:Virus Replication / Q000235:genetics* / Q000502:physiology
chemical_list: D017931:DNA Primers; D009841:Oligonucleotides; D008156:Luciferases
references.citation: Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13535-40
references.pmid: 19628694
references.citation: Nucleic Acids Res. 2006 May 17;34(9):2618-33
references.pmid: 16707664
references.citation: BMC Genomics. 2007 Jul 18;8:243
references.pmid: 17640361
references.citation: Nucleic Acids Res. 2012 Aug;40(14):6908-21
references.pmid: 22561372
references.citation: Nucleic Acids Res. 2003 Jul 1;31(13):3406-15
references.pmid: 12824337
references.citation: Nat Struct Biol. 1998 Jun;5(6):432-6
references.pmid: 9628479
references.citation: PLoS Pathog. 2010 Oct 07;6(10):e1001007
references.pmid: 20949075
references.citation: Methods Mol Biol. 2011;764:279-300
references.pmid: 21748648
references.citation: J Gen Virol. 2009 Jul;90(Pt 7):1659-1669
references.pmid: 19264618
references.citation: Nucleic Acids Res. 2012 Mar;40(6):2540-53
references.pmid: 22127859
references.citation: Nucleic Acids Res. 2014 Jan;42(1):567-82
references.pmid: 24049069
references.citation: Nucleic Acids Res. 2013 Feb 1;41(4):2526-40
references.pmid: 23275555
references.citation: J Virol. 2004 Feb;78(3):1352-66
references.pmid: 14722290
references.citation: RNA. 2003 May;9(5):599-606
references.pmid: 12702818
references.citation: RNA. 2013 Jul;19(7):982-91
references.pmid: 23651615
references.citation: Trends Microbiol. 2014 Jun;22(6):354-64
references.pmid: 24636243
references.citation: J Virol. 1993 May;67(5):2537-45
references.pmid: 8474159
references.citation: J Virol Methods. 2007 Jun;142(1-2):59-66
references.pmid: 17320981
references.citation: J Virol. 2005 Jan;79(1):380-92
references.pmid: 15596831
references.citation: Nucleic Acids Res. 2010 Jul;38(12):4079-91
references.pmid: 20194114
references.citation: Nucleic Acids Res. 2009 Sep;37(16):5498-510
references.pmid: 19578061
references.citation: J Virol. 2008 Sep;82(18):9008-22
references.pmid: 18614633
references.citation: PLoS Pathog. 2013 Mar;9(3):e1003228
references.pmid: 23555245
references.citation: Cell. 1976 Apr;7(4):595-607
references.pmid: 182376
references.citation: Nucleic Acids Res. 2013 Feb 1;41(4):2594-608
references.pmid: 23275571
references.citation: Viruses. 2011 Oct;3(10):2006-24
references.pmid: 22069526
references.citation: Antiviral Res. 2010 Jul;87(1):9-15
references.pmid: 20382185
references.citation: RNA. 2010 May;16(5):913-25
references.pmid: 20360391
references.citation: J Viral Hepat. 2011 Feb;18(2):77-83
references.pmid: 21235686
references.citation: Nucleic Acids Res. 2004 May 11;32(8):2623-31
references.pmid: 15141033
references.citation: FEBS J. 2005 Aug;272(15):3872-86
references.pmid: 16045758